Numerous microRNAs are also associated with HER2+ breast cancer, in particular miR-125b (connected to metastasis and worst patient outcomes) is reported to be upregulated, while miR-181d and miR-195-5p are downregulated (118). Here, ERBB2 is linked to breast carcinoma.